Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZ) Research & Development (2021 - 2024)

Core Scientific's Research & Development history spans 4 years, with the latest figure at $5.0 million for Q4 2024.

  • For Q4 2024, Research & Development rose 167.38% year-over-year to $5.0 million; the TTM value through Dec 2024 reached $11.8 million, up 64.67%, while the annual FY2024 figure was $11.8 million, 64.67% up from the prior year.
  • Research & Development for Q4 2024 was $5.0 million at Core Scientific, up from $2.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $14.8 million in Q2 2022 and bottomed at $1.2 million in Q1 2021.
  • The 4-year median for Research & Development is $2.2 million (2023), against an average of $3.4 million.
  • The largest annual shift saw Research & Development skyrocketed 928.04% in 2022 before it plummeted 88.9% in 2023.
  • A 4-year view of Research & Development shows it stood at $3.4 million in 2021, then dropped by 22.83% to $2.7 million in 2022, then decreased by 29.39% to $1.9 million in 2023, then surged by 167.38% to $5.0 million in 2024.
  • Per Business Quant, the three most recent readings for CORZ's Research & Development are $5.0 million (Q4 2024), $2.8 million (Q3 2024), and $2.2 million (Q2 2024).